Black Diamond Therapeutics Inc (NAS:BDTX)
$ 3.31 0.09 (2.8%) Market Cap: 187.03 Mil Enterprise Value: 82.76 Mil PE Ratio: 0 PB Ratio: 1.68 GF Score: 41/100

Black Diamond Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 07, 2022 / 01:30PM GMT
Release Date Price: $1.94 (+7.18%)
Operator

Hello, and welcome to the 2022 Virtual Annual Meeting of Black Diamond Therapeutics, Inc. Please note that today's meeting is being recorded. (Operator Instructions)

Bob Ingram
Black Diamond Therapeutics, Inc. - Co-Founder, President & CEO

Good morning, everyone. My name is Bob Ingram. It's my privilege to chair the Board of Directors of Black Diamond Therapeutics, Inc.

The meeting is now called to order. I've asked Marishka DeToy of Goodwin Procter LLP, our outside legal counsel, to record the minutes.

It is a pleasure to welcome our stockholders and visitors to the 2022 Annual Meeting of Stockholders of Black Diamond Therapeutics, Inc. This meeting is being held in accordance with the company's bylaws and Delaware law. In light of continuing public health concerns resulting from the ongoing COVID-19 pandemic, we are conducting the annual meeting virtually again, instead of an in-person meeting, to protect the health and safety of our stockholders and employees. We have stockholders attending via the web portal we provided.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot